Epigenetic mechanisms regulate ΔNP73 promoter function in human tonsil B cells

Molecular Immunology

Volumn 48, Issue 4, 2011, Pages 408-414

  Brigati, Claudio ^a   Banelli, Barbara ^a   Casciano, Ida ^a   Di Vinci, Angela ^a   Matis, Serena ^a   Cutrona, Giovanna ^a   Forlani, Alessandra ^a   Allemanni, Giorgio ^a   Romani, Massimo ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

B cells; DNA methylation; Epigenetics; TP73

Indexed keywords

DELTA NP73; DNA; GENE PRODUCT; HISTONE; MESSENGER RNA; NUCLEAR PROTEIN; UNCLASSIFIED DRUG;

ADOLESCENT; AMINO ACID SEQUENCE; ARTICLE; B LYMPHOCYTE; CELL FRACTIONATION; CHILD; CHROMATIN; EPIGENETICS; GENE EXPRESSION; GENE FUNCTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMORAL IMMUNITY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; SCHOOL CHILD; SENSITIVITY ANALYSIS; TONSIL;

ADOLESCENT; B-LYMPHOCYTES; BASE SEQUENCE; BINDING SITES; CELL COUNT; CHILD; CHILD, PRESCHOOL; CHROMATIN; CHROMATIN IMMUNOPRECIPITATION; DNA METHYLATION; DNA-BINDING PROTEINS; EPIGENESIS, GENETIC; HUMANS; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; PALATINE TONSIL; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; TRANSCRIPTION FACTOR AP-1; TRANSFECTION; TUMOR SUPPRESSOR PROTEINS;

EID: 78650617897     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2010.09.001     Document Type: Article

References (33)

1. Andrews N.C., Faller D.V. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res. 1991, 19:2499.
2. Banelli B., Bonassi S., Casciano I., Mazzocco K., Di Vinci A., Scaruffi P., Brigati C., Allemanni G., Borzi L., Tonini G.P., Romani M. Outcome prediction and risk assessment by quantitative pyrosequencing methylation analysis of the SFN gene in advanced stage, high-risk, neuroblastic tumor patients. Int. J. Cancer 2010, 126:656-668.
3. Banelli B., Casciano I., Croce M., Di Vinci A., Gelvi I., Pagnan G., Brignole C., Allemanni G., Ferrini S., Ponzoni M., Romani M. Expression and methylation of CASP8 in neuroblastoma: identification of a promoter region. Nat. Med. 2002, 8:1333-1335. author reply 1335.
4. Bueso-Ramos C., Xu Y., McDonnell T.J., Brisbay S., Pierce S., Kantarjian H., Rosner G., Garcia-Manero G. Protein expression of a triad of frequently methylated genes, p73, p57Kip2, and p15, has prognostic value in adult acute lymphocytic leukemia independently of its methylation status. J. Clin. Oncol. 2005, 23:3932-3939.
5. Cabrera-Socorro A., Pueyo Morlans M., Suarez Sola M.L., Gonzalez Delgado F.J., Castaneyra-Perdomo A., Marin M.C., Meyer G. Multiple isoforms of the tumor protein p73 are expressed in the adult human telencephalon and choroid plexus and present in the cerebrospinal fluid. Eur. J. Neurosci. 2006, 23:2109-2118.
6. Casciano I., Banelli B., Croce M., Allemanni G., Ferrini S., Tonini G.P., Ponzoni M., Romani M. Role of methylation in the control of DeltaNp73 expression in neuroblastoma. Cell Death Differ. 2002, 9:343-345.
7. Casciano I., Mazzocco K., Boni L., Pagnan G., Banelli B., Allemanni G., Ponzoni M., Tonini G.P., Romani M. Expression of DeltaNp73 is a molecular marker for adverse outcome in neuroblastoma patients. Cell Death Differ. 2002, 9:246-251.
8. Corn P.G., Kuerbitz S.J., van Noesel M.M., Esteller M., Compitello N., Baylin S.B., Herman J.G. Transcriptional silencing of the p73 gene in acute lymphoblastic leukemia and Burkitt's lymphoma is associated with 5' CpG island methylation. Cancer Res. 1999, 59:3352-3356.
9. Cutrona G., Colombo M., Matis S., Reverberi D., Dono M., Tarantino V., Chiorazzi N., Ferrarini M. B lymphocytes in humans express ZAP-70 when activated in vivo. Eur. J. Immunol. 2006, 36:558-569.
10. Di Vinci A., Sessa F., Casciano I., Banelli B., Franzi F., Brigati C., Allemanni G., Russo P., Dominioni L., Romani M. Different intracellular compartmentalization of TA and DeltaNp73 in non-small cell lung cancer. Int. J. Oncol. 2009, 34:449-456.
11. Dono M., Burgio V.L., Colombo M., Sciacchitano S., Reverberi D., Tarantino V., Cutrona G., Chiorazzi N., Ferrarini M. CD5+ B cells with the features of subepithelial B cells found in human tonsils. Eur. J. Immunol. 2007, 37:2138-2147.
12. Dono M., Burgio V.L., Tacchetti C., Favre A., Augliera A., Zupo S., Taborelli G., Chiorazzi N., Grossi C.E., Ferrarini M. Subepithelial B cells in the human palatine tonsil. I. Morphologic, cytochemical and phenotypic characterization. Eur. J. Immunol. 1996, 26:2035-2042.
13. Falk K.I., Ernberg I. Demethylation of the Epstein-Barr virus origin of lytic replication and of the immediate early gene BZLF1 is DNA replication independent. Brief report. Arch. Virol. 1999, 144:2219-2227.
14. Flores E.R., Sengupta S., Miller J.B., Newman J.J., Bronson R., Crowley D., Yang A., McKeon F., Jacks T. Tumor predisposition in mice mutant for p63 and p73: evidence for broader tumor suppressor functions for the p53 family. Cancer Cell. 2005, 7:363-373.
15. Grob T.J., Novak U., Maisse C., Barcaroli D., Luthi A.U., Pirnia F., Hugli B., Graber H.U., De Laurenzi V., Fey M.F., Melino G., Tobler A. Human delta Np73 regulates a dominant negative feedback loop for TAp73 and p53. Cell Death Differ. 2001, 8:1213-1223.
16. Kawano S., Miller C.W., Gombart A.F., Bartram C.R., Matsuo Y., Asou H., Sakashita A., Said J., Tatsumi E., Koeffler H.P. Loss of p73 gene expression in leukemias/lymphomas due to hypermethylation. Blood 1999, 94:1113-1120.
17. Lamph W.W., Wamsley P., Sassone-Corsi P., Verma I.M. Induction of proto-oncogene JUN/AP-1 by serum and TPA. Nature 1988, 334:629-631.
18. Leupin N., Luthi A., Novak U., Grob T.J., Hugli B., Graber H., Fey M.F., Tobler A. P73 status in B-cell chronic lymphocytic leukaemia. Leuk. Lymphoma 2004, 45:1205-1207.
19. Lissy N.A., Davis P.K., Irwin M., Kaelin W.G., Dowdy S.F. A common E2F-1 and p73 pathway mediates cell death induced by TCR activation. Nature 2000, 407:642-645.
20. Melino G., De Laurenzi V., Vousden K.H. p73: friend or foe in tumorigenesis. Nat. Rev. Cancer 2002, 2:605-615.
21. Nakagawa T., Takahashi M., Ozaki T., Watanabe K., Hayashi S., Hosoda M., Todo S., Nakagawara A. Negative autoregulation of p73 and p53 by DeltaNp73 in regulating differentiation and survival of human neuroblastoma cells. Cancer Lett. 2003, 197:105-109.
22. Novak U., Grob T.J., Baskaynak G., Peters U.R., Aebi S., Zwahlen D., Tschan M.P., Kreuzer K.A., Leibundgut E.O., Cajot J.F., Tobler A., Fey M.F. Overexpression of the p73 gene is a novel finding in high-risk B-cell chronic lymphocytic leukemia. Ann. Oncol. 2001, 12:981-986.
23. Pascual V., Liu Y.J., Magalski A., de Bouteiller O., Banchereau J., Capra J.D. Analysis of somatic mutation in five B cell subsets of human tonsil. J. Exp. Med. 1994, 180:329-339.
24. Sato H., Oka T., Shinnou Y., Kondo T., Washio K., Takano M., Takata K., Morito T., Huang X., Tamura M., Kitamura Y., Ohara N., Ouchida M., Ohshima K., Shimizu K., Tanimoto M., Takahashi K., Matsuoka M., Utsunomiya A., Yoshino T. Multi-step aberrant CpG island hyper-methylation is associated with the progression of adult T-cell leukemia/lymphoma. Am. J. Pathol. 2010, 176:402-415.
25. Siu L.L., Chan J.K., Wong K.F., Kwong Y.L. Specific patterns of gene methylation in natural killer cell lymphomas: p73 is consistently involved. Am. J. Pathol. 2002, 160:59-66.
26. Stiewe T. The p53 family in differentiation and tumorigenesis. Nat. Rev. Cancer 2007, 7:165-168.
27. Stiewe T., Tuve S., Peter M., Tannapfel A., Elmaagacli A.H., Putzer B.M. Quantitative TP73 transcript analysis in hepatocellular carcinomas. Clin. Cancer Res. 2004, 10:626-633.
28. Tomasini R., Tsuchihara K., Wilhelm M., Fujitani M., Rufini A., Cheung C.C., Khan F., Itie-Youten A., Wakeham A., Tsao M.S., Iovanna J.L., Squire J., Jurisica I., Kaplan D., Melino G., Jurisicova A., Mak T.W. TAp73 knockout shows genomic instability with infertility and tumor suppressor functions. Genes Dev. 2008, 22:2677-2691.
29. Tost J., Gut I.G. DNA methylation analysis by pyrosequencing. Nat. Protoc. 2007, 2:2265-2275.
30. Vossio S., Palescandolo E., Pediconi N., Moretti F., Balsano C., Levrero M., Costanzo A. DN-p73 is activated after DNA damage in a p53-dependent manner to regulate p53-induced cell cycle arrest. Oncogene 2002, 21:3796-3803.
31. Wan Y.Y., DeGregori J. The survival of antigen-stimulated T cells requires NFkappaB-mediated inhibition of p73 expression. Immunity 2003, 18:331-342.
32. Yang A., Walker N., Bronson R., Kaghad M., Oosterwegel M., Bonnin J., Vagner C., Bonnet H., Dikkes P., Sharpe A., McKeon F., Caput D. p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours. Nature 2000, 404:99-103.
33. Zaika A.I., Slade N., Erster S.H., Sansome C., Joseph T.W., Pearl M., Chalas E., Moll U.M. DeltaNp73, a dominant-negative inhibitor of wild-type p53 and TAp73, is up-regulated in human tumors. J. Exp. Med. 2002, 196:765-780.